A phase 2 study evaluated meaningful activity from lifileucel for patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors.
Lifileucel demonstrated clinically meaningful activity in patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors, according to findings from a subgroup of patients in the phase 2 C-144-01 study.
Jeffrey Huffman republicaneagle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from republicaneagle.com Daily Mail and Mail on Sunday newspapers.
Jeffrey Huffman - Post Bulletin | Rochester Minnesota news, weather, sports postbulletin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from postbulletin.com Daily Mail and Mail on Sunday newspapers.